Most Recent
A judge asked to approve an $11 million settlement in a class action against retirement village provider Aveo is considering a proposal by court-appointed contradictors to set aside a percentage of the sum for group members, which would leave the law firm running the case $2 million out of pocket.
A judge has signed off on a $18.5 million settlement in a six-year-old shareholder class action against Deloitte over its audits of collapsed construction group Hastie, saying the amount might be "disappointing" to group members but reflected the risks of going to trial.
The law firm that's running a franchisee class action against United Petroleum over allegedly loss-making Pie Faces stores has has won its bid to peek at draft communications the oil giant wants to send to group members.
A self-represented applicant is challenging the permanent stay of his competition class action against Google and Meta over the digital companies' decision to ban cryptocurrency ads.
A judge who signed off on a settlement in a class action against the government by sovereign bondholders over the disclosure of climate risks said proving climate change posed a risk to government coffers may not be as difficult as the government has claimed.
The High Court has granted special leave to farmers in a class action against Advanta Seeds over allegedly contaminated product to challenge a court's finding that a disclaimer nullified the company's duty to protect growers against economic loss.
The future of a competition class action against AGL Energy is in doubt after being abandoned by its funder, despite evading the energy supplier’s bid to dismiss the case.
A second law firm is likely to throw its hat in the ring to run a competing class action against Qantas over flight cancellations in the COVID-19 pandemic, but a judge has made orders trying to side-step a carriage fight, criticising them as “wasteful and expensive”.
A judge has approved the settlement of a class action brought on behalf of sovereign bondholders over the disclosure of climate change risks, despite a late scrap with the government over whether the deal puts a stop to future cases.
An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.